X0306 4 2021-11-15 false 0001603756 Axonics, Inc. AXNX 0001756437 Woock John 26 TECHNOLOGY DRIVE IRVINE CA 92618 false true false false Chief Marketing Officer Common Stock 2021-11-15 4 M false 5000.00 14.19 A 29932.00 D Common Stock 2021-11-15 4 S false 2016.00 60.1235 D 27916.00 D Common Stock 2021-11-15 4 S false 2984.00 60.7279 D 24932.00 D Stock Option (Right to Buy) 14.19 2021-11-15 4 M false 5000.00 0.00 D 2029-01-30 Common Stock 5000.00 30555.00 D This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 15, 2021. This transaction was executed in multiple trades at prices ranging from $59.54 to $60.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $60.57 to $60.835. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The option becomes exercisable as follows: (i) 1/4 of the total number of shares of common stock underlying the option will vest on January 30, 2020 and (ii) 1/36 of the remaining shares of common stock underlying the option will vest monthly thereafter, such that the option will fully vest on January 30, 2023, provided the reporting person remains in continuous service on each vesting date. /s/ Dan Dearen, as Attorney-in-Fact for John Woock, Ph.D 2021-11-17